Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 68

Tests names and labsConditionsGenes and analytesMethods

CYP2C19

Genelex
United States
21
  • T Targeted variant analysis

CYP2C19

Department of Laboratory Medicine P.D. Hinduja National Hospital - MRC
India
12
  • T Targeted variant analysis

CYP2C19-related poor drug metabolism (sequence analysis of CYP2C19 gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

CYP2C19

MVZ Dortmund Dr. Eberhard & Partner
Germany
11
  • E Sequence analysis of select exons

CYP2C19, major genotyping

Molecular Diagnostics Laboratory Seoul National University Hospital
South Korea
11
  • E Sequence analysis of select exons

Cytochrome P450 2C19, CYP2C19 - 9 Variants

ARUP Laboratories, Molecular Genetics and Genomics ARUP laboratories
United States
41
  • T Targeted variant analysis

CYP2C19 drug metabolizing enzyme gene mutation

Molecular Diagnostics Children's Hospital of Wisconsin
United States
11
  • -- Targeted variant analysis

CYP2C19 Single Gene

Fulgent Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CYP2C19, Genotyping

Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University
United States
11
  • T Targeted variant analysis

Susceptibility to Drugs , Sequencing CYP2C19 Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Cytochrome P450 (23 alleles of CYP2C19, CYP2D6 and CYP2C9)

CGC Genetics
Portugal
33
  • T Targeted variant analysis

Cytochrome P450 (6 alleles of CYP2D6, CYP2C9, CYP2C19 and CYP3A4)

CGC Genetics
Portugal
34
  • T Targeted variant analysis

AccuType(R) CP, Clopidogrel CYP2C19 Genotype (NY)

Quest Diagnostics Nichols Institute San Juan Capistrano
United States
11
  • T Targeted variant analysis

AccuType(R) CP, Clopidogrel CYP2C19 Genotype

Quest Diagnostics Nichols Institute San Juan Capistrano
United States
11
  • T Targeted variant analysis

CYP2C19 Plavix Activation

True Health Diagnostics
United States
11
  • T Targeted variant analysis

CYP2C19 genotyping

Alpha Genomix Laboratories
United States
111
  • T Targeted variant analysis

Clopidogrel response

Xcode Life
India
22
  • T Targeted variant analysis

CYP450 Genotype

FirmaLab
United States
33
  • C Sequence analysis of the entire coding region

Core DME Panel

Castle Medical Molecular Diagnostics Castle Medical, LLC
United States
22
  • T Targeted variant analysis

Cytochrome P450 2C19

Molecular Diagnostics Laboratories
United States
11
  • T Targeted variant analysis

Results: 1 to 20 of 68

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center